SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-012521
Filing Date
2018-11-13
Accepted
2018-11-13 16:08:47
Documents
3
Period of Report
2018-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_nov122018.htm 8-K 37920
2 PRESS RELEASE ex99-1.htm EX-99.1 15653
3 IMAGE vtgn.jpg GRAPHIC 6742
  Complete submission text file 0001654954-18-012521.txt   64174
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 181178005
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1